Bayer is dedicated to providing treatment options for people living with rare, serious and life-threatening hematologic diseases. Bayer has been a committed partner to the hemophilia community delivering therapeutic options, educational and support programs and continuing research designed to meet the needs of patients throughout their life journey.

Click HERE for Bayer’s QR code.

https://pharma.bayer.com/hemophilia

Please see full Prescribing Information

Learn More About Bayer's Latest EHL Treatment Option

See Comparative PK Study Data for Bayer's EHL Product

PK and You, How PK Can Help You Individualize Your Treatment